Simplify Asset Management »

Stoke Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $406k 103k 3.94
2023-06-30 $1.3M 123k 10.63
2023-03-31 $1.0M 123k 8.33

More positions owned by Simplify Asset Management

Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Core S&p500 Etf (IVV)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Tesla Motors Call Option (TSLA)
Applied Therapeutics (APLT)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Ishares Tr Mbs Etf (MBB)
Tscan Therapeutics (TCRX)
Simplify Exchange Traded Fun High Yield Plus (CDX)

View all positions for Simplify Asset Management

Top funds holding Stoke Therapeutics

Skorpios Trust
Cowen And Company
Lynx1 Capital Management
Redmile Group
Baker Bros. Advisors
Vanguard Group
Goldman Sachs Group
Cormorant Asset Management
Deutsche Bank Aktiengesellschaft
Healthcare Of Ontario Pension Plan Trust Fund
Dimensional Fund Advisors
Charles Schwab Investment Management
Jacobs Levy Equity Management
D. E. Shaw & Co
GSA Capital Partners

View all funds holding Stoke Therapeutics